Conceptio
›
Archive
›
ClinicalTrials.gov
ClinicalTrials.gov
public full text
A Study to Evaluate the Efficacy and Safety of the Combination of TQ-B211 Plus Docetaxel in Patients With HER2-positive MBC.
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
· 2018
ClinicalTrials.gov · Datasets · License: Public Domain · 2018
Open Source ↗
her2-positive metastatic breast cancer, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Temozolomide and Radiation Therapy With or Without Bevacizumab in Treating Patients With Newly Diagnosed Glioblastoma
#1128338
A STUDY TO ESTIMATE THE EFFECT OF PF-06651600 ON THE PHARMACOKINETICS (PK) OF ORAL CONTRACEPTIVE (OC)
#1128333
Trial Evaluating the Diagnostic Usefulness of Lumentin® 44 When Used as Contrast Agent
#1128334
Physical Exercise Augmented CBT for GAD
#1128335
Simultaneous Boost in Neoadjuvant Radiotherapy for Rectal Cancer
#1128337
Record
· ID 804338
Retrieved via
Conceptio
— every document is proof-bundled with source, license, and retrieval metadata.